Kolkata/Singapore | September 4, 2026 | INFRAINTEL Bureau
(Healthcare IT News)
Parkway Cancer Centre says the number of patients travelling from India increased by nearly 20 per cent in 2025, with most arriving after their disease had advanced or resisted earlier treatment.
Medical director Dr Ang Peng Tiam estimated that 60 to 70 per cent of Indian patients approaching the Singapore centre have advanced or treatment-resistant cancers, while around 30 per cent remain at a potentially curable stage.
He emphasised accurate pathology, staging and molecular profiling and said some patients with specific mutations may benefit substantially from targeted therapies. The centre aims to complete major diagnostic work within 48 hours in many overseas cases.
Treatment costs vary widely by cancer type, stage, medicine and number of cycles. Dr Ang said prevention, tobacco and betel-nut awareness, screening and clear doctor-patient communication are critical to improving outcomes.
The figures are based on one provider’s patient flow and should not be treated as representative of all Indian cancer cases. They nevertheless underline the need for earlier detection, affordable molecular diagnostics, referral pathways, domestic oncology capacity and transparent counselling on benefits, risks and costs of overseas care.